VEGFA and age-related macular degeneration: Accordingly, anti-VEGF therapy is the approved treatment for AMD and PDR and for some solid tumours such as colorectal and lung cancers, glioblastoma, renal cancer, hepatocellular carcinoma and gastrointestinal stromal tumours [86].